Silo Pharma
SILO
6 hedge funds and large institutions have $72.3K invested in Silo Pharma in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
50% more funds holding
Funds holding: 4 → 6 (+2)
0.12% less ownership
Funds ownership: 0.17% → 0.05% (-0.12%)
74% less capital invested
Capital invested by funds: $273K → $72.3K (-$201K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
+$58.5K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.56K |
| 3 |
FIM
FWL Investment Management
Dallas,
Texas
|
+$293 |
| 4 |
Wells Fargo
San Francisco,
California
|
+$59 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
-$144K |
| 2 |
SC
Shay Capital
New York
|
-$92K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$6.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FAIM
1
Financial Advocates Investment Management
Olympia,
Washington
| $50.4K | +$58.5K | +1,000 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $17.5K | -$6.2K | -106 | -23% |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $4K | +$4.56K | +78 | New |
|
|
FIM
4
FWL Investment Management
Dallas,
Texas
| $269 | +$293 | +5 | New |
|
|
5
Wells Fargo
San Francisco,
California
| $64 | +$59 | +1 | New |
|
6
Morgan Stanley
New York
| $17 | – | – | – |
|
|
FIA
7
FNY Investment Advisers
New York
| – | -$144K | -1,791 | Closed |
|
|
SC
8
Shay Capital
New York
| – | -$92K | -1,134 | Closed |
|
SILO Hedge Fund Activity: Q4 2022 in Review
6 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Silo Pharma (SILO) for Q4 2022, worth a combined $72.3K — down 74% from $273K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new SILO positions and 2 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Financial Advocates Investment Management, opening a new position worth an estimated $58.5K. The largest seller was FNY Investment Advisers, exiting entirely with an estimated $144K sold.
- 6 institutional investors held Silo Pharma (SILO) as of Q4 2022, up from 4 in Q3 2022.
- Funds reported $72.3K of Silo Pharma stock for Q4 2022, down 74% quarter-over-quarter.
- 4 funds opened new Silo Pharma positions in Q4 2022 and 2 closed out, a net change of +2 holders.
- The largest Silo Pharma buyer in Q4 2022 was Financial Advocates Investment Management, an estimated $58.5K added.
- The largest Silo Pharma seller in Q4 2022 was FNY Investment Advisers, an estimated $144K sold.
Based on aggregated 13F filings for Q4 2022.